iSpecimen amends Series C Preferred Stock terms to add anti-dilution adjustment for reverse splits

iSpecimen Inc.

On Jan 16, 2026, iSpecimen filed amended Certificate of Designation for Series C Convertible Non-Voting Preferred Stock.
Amendment adjusts Conversion Price and Floor Price proportionately on any reverse stock split or share combination.
Approved by holders of majority of outstanding Series C Preferred Stock per Section 23 of original designation.
No other changes to terms, preferences, or privileges of Series C Preferred Stock.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.